Related Experiment Video
Updated: Feb 10, 2026

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
Published on: December 9, 2021
Stroke Promotes Systemic Endothelial Inflammation and Atherosclerosis
Ruslan Rust1, Anna-Sophie Hofer1, Martin E Schwab2
1Brain Research Institute, University of Zurich, Switzerland; Department of Health Sciences and Technology, ETH Zurich, Switzerland; These authors contributed equally to this work.
Stroke survivors face higher risks of recurrent vascular events. New research indicates brain-released alarmins drive atherosclerosis and inflammation, suggesting potential therapeutic targets.
Area of Science:
- Neuroscience
- Cardiovascular Medicine
- Immunology
Background:
- Patients surviving a stroke exhibit elevated risks for subsequent vascular events.
- The precise biological mechanisms driving these recurrent events remain largely unelucidated.
- Atherosclerosis, a key contributor to vascular events, may be exacerbated post-stroke.
Purpose of the Study:
- To investigate the potential role of brain-derived factors in post-stroke vascular complications.
- To explore the link between stroke, alarmins, and systemic vascular inflammation.
- To identify novel therapeutic strategies targeting stroke-induced atherosclerosis.
Main Methods:
- The study proposes investigating the release of alarmins from the brain following a stroke.
- It suggests analyzing the systemic effects of these alarmins on vascular inflammation.
- The research aims to correlate these findings with plaque formation in blood vessels.
Main Results:
- A recent study suggests that stroke triggers the release of alarmins from the brain.
- These alarmins appear to induce systemic vascular inflammation.
- This inflammation is associated with the development and progression of atherosclerotic plaques.
Conclusions:
- Stroke-induced alarmin release may be a critical mechanism promoting atherosclerosis.
- Targeting these brain-released alarmins could offer novel therapeutic avenues.
- Interfering with this pathway may reduce the risk of recurrent vascular events in stroke survivors.
Related Concept Videos
Inflammation
Atherosclerosis III: Management
Atherosclerosis I: Introduction
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

